Differential Responses to Chemoimmunotherapy in Patients with Metastatic Malignant Melanoma

Author： Mainwaring P.N. Atkinson H. Chang J. Moore J. Hancock B.W. Guillou P.J. Oskam R. Gore M.E.

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.9, 1997-08, pp. : 1388-1392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignant Melanoma Metastatic to the Ovary

By Piura B. Kedar I. Ariad S. Meirovitz M. Yanai-Inbar I.

Gynecologic Oncology, Vol. 68, Iss. 2, 1998-02 ,pp. : 201-205

Elsevier

Access to resources Recommend Favorite

Serum VEGF-C is associated with metastatic site in patients with malignant melanoma

By Vihinen Pia P. Hilli Johanna Vuoristo Meri-Sisko Syrjänen Kari J. Kähäri Veli-Matti Pyrhönen Seppo O.

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 678-684

Informa Healthcare

Access to resources Recommend Favorite

Serum interleukin-6 concentrations as predictive factor of time to progression in metastatic malignant melanoma patients treated by biochemotherapy: a retrospective study

By Olivier Rixe Jean-baptiste Meric David Khayat Claude Soubrane Roger Mouawad

Cytokines, Cellular & Molecular Therapy, Vol. 7, Iss. 4, 2002-12 ,pp. : 151-156

Informa Healthcare

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A. Binder M. Steiner A. Wolff K. Pehamberger H.

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Malignant Melanoma Metastatic to the Ovary: Presentation and Radiological Characteristics

By Moselhi M. Spencer J. Lane G.

Gynecologic Oncology, Vol. 69, Iss. 2, 1998-05 ,pp. : 165-168

Elsevier

Access to resources Recommend Favorite